{"disease":{"id":"epilepsy-treatment-refractory","name":"epilepsy treatment refractory"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06832020","title":"Determinants of Adaptive Behavior Through the Vineland Scale in Pediatric Patients With Severe and Drug-resistant Epilepsy","phase":"","overall_status":"COMPLETED","enrollment_count":369,"lead_sponsor_name":"Ana Valeria Duarte Oliveira","has_results":false},{"nct_id":"NCT06863350","title":"Percutaneous Repair for Drug - Resistant Epilepsy by Intervention of Closing the Patent Foramen Ovale（PREDICT-PFO Trial）","phase":"NA","overall_status":"RECRUITING","enrollment_count":180,"lead_sponsor_name":"Sichuan University","has_results":false},{"nct_id":"NCT05845255","title":"Evaluation of the Epilepsy-related Quality of Life, Seizure-related Accidents and Validation of the Mjn-SERAS Solution in the Normalised Patient Environment with Real-World Data","phase":"","overall_status":"RECRUITING","enrollment_count":130,"lead_sponsor_name":"MJN Neuroserveis, S.L","has_results":false},{"nct_id":"NCT06762743","title":"Bioequivalence Study of Two Brivaracetam Oral Solutions in Healthy Adults Under Fasting and High-Fat Meal Conditions","phase":"PHASE1","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":60,"lead_sponsor_name":"Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd.","has_results":false},{"nct_id":"NCT07220161","title":"Trigeminal Nerve Stimulation of the Treatment of Epilepsy","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":24,"lead_sponsor_name":"Baylor College of Medicine","has_results":false},{"nct_id":"NCT07378397","title":"OPM MEG in Pre-surgical Mapping for Patients With Epilepsy","phase":"","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":20,"lead_sponsor_name":"Aston University","has_results":false},{"nct_id":"NCT07249190","title":"A Study to Evaluate the Safety and Effectiveness of Magnetic Resonance-Guided Ultrasound Ablation of the Anterior Nucleus of Thalamus for the Treatment of Drug-resistant Epilepsy.","phase":"PHASE1","overall_status":"NOT_YET_RECRUITING","enrollment_count":20,"lead_sponsor_name":"Chinese PLA General Hospital","has_results":false},{"nct_id":"NCT06952764","title":"Epilepsy Cycles Longitudinal Monitoring to Inform Personalized Seizure-risk Estimation (ECLIPSE)","phase":"NA","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":14,"lead_sponsor_name":"Insel Gruppe AG, University Hospital Bern","has_results":false},{"nct_id":"NCT06593444","title":"Thalamic Ventral Intermediate Electrical Stimulation for Refractory Familial Cortical Myoclonus with Epilepsy","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":5,"lead_sponsor_name":"Xuanwu Hospital, Beijing","has_results":false}],"total":9},"guidelines":[],"source":"Drug Landscape verified database"}